rHEALTH is focused on helping astronauts mitigate these challenges through providing advanced diagnostics and health AI to prolong precious human life in space and on other planets.
A single system
Powerful intelligence
Your health in minutes
- E. Chan
In space, there needs to be rapid diagnosis of cell counts and coagulation in the event of trauma, an accident, or the need to perform blood transfusions. This very same use parallels the need on Earth.
For trauma
Blood cell conditions
Tailored to reduce bleeding risk
State-of-art AI and diagnostics working in tandem
Management of clotting and hematology disorders requires frequent in-person visits, multiple tests, and lack of personalized information, especially when it comes to associating the best treatment plan for you. Multiple $10s of billions are spent per year on treatment, therapies, and testing, and with rHEALTH, there is a better way that improves outcomes. Both clotting and blood cell disorders are time-intensive for patients and also current tools for their management outside the hospital are inadequate. Part of the reason is the hematocrit effect and another is the lack of accurate metering and mixing for existing commercially-available analyzers. The rHEALTH Awesome device provides performance that meets or exceeds central lab standards. Our FVIII hemophilia A solution has been developed with support from Biogen and the NIH and provides hemophilia A patients the ability to monitor their factor replacement levels. Our approach will allow these patients to monitor their clotting status anywhere and anytime, prior to sports and to identify optimal therapeutic regimens. Additional coagulation tests will be utilize to monitor heparins, INR, and direct Xa inhibitors. The rHEALTH technology has also been demonstrated, in conjunction with AstraZeneca, to be highly accurate in measurement of thrombocytopenia, a condition of low platelets which can arise from certain drugs, vaccines, or immunological conditions.
Coagulation status and measurement is vital to health. Our rHEALTH Awesome device runs our CE-marked two-stage fluorogenic FVIII assay for hemophilia A patients.
Our fluorogenic two-stage FVIII assay for hemophilia A patients allows measurement of across the full desired range with a single set of standards.
No human has been born in space. In order to ensure the propagation of our species, we may need to use assisted reproductive methods to help us colonize a different planet. These would be the same reproductive health methods we use on Earth.
Most up-to-date information integrated with AI to provide the best outcomes
Easiest, most streamlined testing for IVF
Provides optimal patient experience
Today’s birth rates are dropping. Couples are older as they have decide to have children and many have difficulty in conceiving. IVF monitoring is one of the most diagnostically intense medical procedures, often requiring thousands of dollars of tests per cycle. It is estimated that over 2 million cycles were performed last year (www.eshre.eu), making this a > $2B market. We are striving to streamline this process for couples trying to conceive, by providing a high-performing monitoring approach, in the comfort of their homes. We analyze this data to provide the optimal treatment recommendations so your reproductive endocrinologist can best tailor your cycle.
US women are waiting longer to have children and consequently, there is a greater reliance on IVF procedures (www.cdc.gov).
*rHEALTH devices are limited by FDA regulation for research or investigational purposes only.
